• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
• 3. Evolution of important glucosinolates in three common Brassica vegetables during their processing into vegetable powder and in vitro gastric digestion
  Nan Fu,Naphaporn Chiewchan,Xiao Dong Chen Food Funct., 2020,11, 211-220
• 4. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 5. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119

• Solvents and Organic Chemicals Organic Compounds Benzenoids Naphthalenes Naphthalene sulfonic acids and derivatives 1-naphthalene sulfonic acids and derivatives

Recent Advances in Naphthalene-1-sulfonamide (606-25-7) Research: A Comprehensive Review

Naphthalene-1-sulfonamide (CAS: 606-25-7) has garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This compound, characterized by its sulfonamide functional group attached to a naphthalene ring, has been extensively studied for its potential as a scaffold in the design of novel therapeutic agents. Recent studies have highlighted its role in modulating various biological targets, including enzymes and receptors, making it a promising candidate for further investigation.

One of the key areas of research involving naphthalene-1-sulfonamide is its application in the development of enzyme inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of naphthalene-1-sulfonamide exhibit potent inhibitory activity against carbonic anhydrase isoforms, which are implicated in conditions such as glaucoma and cancer. The study utilized molecular docking and kinetic assays to elucidate the binding mechanisms, revealing that the sulfonamide group plays a critical role in coordinating with the zinc ion in the enzyme's active site.

In addition to its enzyme inhibitory properties, naphthalene-1-sulfonamide has also been explored for its antimicrobial potential. A recent preprint on bioRxiv reported the synthesis of a series of naphthalene-1-sulfonamide derivatives with enhanced activity against multidrug-resistant bacterial strains. The researchers employed a combination of in vitro and in silico approaches to identify structural modifications that improve antibacterial efficacy while minimizing cytotoxicity. These findings underscore the compound's potential as a lead structure for next-generation antibiotics.

Another noteworthy development is the use of naphthalene-1-sulfonamide in targeted drug delivery systems. A 2024 study in Advanced Drug Delivery Reviews highlighted the incorporation of this compound into nanoparticles designed for selective accumulation in tumor tissues. The sulfonamide moiety was found to enhance the nanoparticles' affinity for tumor-associated carbonic anhydrase, thereby improving therapeutic efficacy and reducing off-target effects. This innovative approach opens new avenues for precision medicine in oncology.

Despite these advancements, challenges remain in optimizing the pharmacokinetic and pharmacodynamic properties of naphthalene-1-sulfonamide-based compounds. Recent research has focused on addressing issues such as solubility and metabolic stability through structural modifications. For instance, a study in the European Journal of Medicinal Chemistry introduced halogenated derivatives of naphthalene-1-sulfonamide, which demonstrated improved oral bioavailability and prolonged half-life in preclinical models.

In conclusion, naphthalene-1-sulfonamide (606-25-7) continues to be a valuable scaffold in chemical biology and pharmaceutical research. Its diverse applications, ranging from enzyme inhibition to antimicrobial activity and drug delivery, highlight its versatility and potential for future therapeutic development. Ongoing research efforts are expected to further elucidate its mechanisms of action and optimize its clinical utility, paving the way for innovative treatments in various disease areas.

• 49650-84-2(1,5-Naphthalenedisulfonamide)
• 16993-45-6(benzene-1,4-disulfonamide)
• 65227-54-5(1-Naphthalenesulfonicacid, hydrazide)
• 76890-77-2(Phenyl, 4-(aminosulfonyl)-)
• 18522-93-5(Benzenesulfonamide,sodium salt (1:1))
• 98-10-2(Benzenesulfonamide)
• 1576-47-2(Naphthalene-2-sulfonamide)
• 3701-01-7(Benzene-1,3-disulfonamide)
• 17286-26-9(1-Naphthalenesulfonamide,5-hydroxy-)
• 64058-62-4(Benzenesulfonamide,4-mercapto-)